MRNA Form 144: 25,770 shares tied to option exercise
Moderna, Inc. (MRNA) reported a Form 144 notice indicating securities were sold or to be sold under Rule 144 related to a stock option exercise on 06/18/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Moderna, Inc. (MRNA) reported a Form 144 notice indicating securities were sold or to be sold under Rule 144 related to a stock option exercise on 06/18/2026. The filing lists 25,770 shares tied to the June 18, 2026 exercise and a separate sale of 36,759 shares on 05/08/2026, with dollar amounts shown in the filing. The transaction method for the exercise is listed as cash and the broker-dealer noted is Fidelity Brokerage Services LLC.
Insights
Rule 144 notice for exercised/options-related sales filed, procedural disclosure only.
The filing lists a stock option exercise with 25,770 shares on 06/18/2026 and a prior sale of 36,759 shares on 05/08/2026. It names Fidelity Brokerage Services LLC as the broker-dealer and records cash as the settlement method.
These notices are routine compliance disclosures under Rule 144. The timing, beneficial ownership status, and any holding-period or volume-limit qualifiers are not shown in the excerpt; future filings or full Form 144 text would clarify whether sales were permitted under Rule 144 conditions.
Key Figures
Key Terms
Rule 144 regulatory
Stock Option Exercise financial
Broker‑dealer financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does MRNA's Form 144 filing mean?
Who acted as broker-dealer on the reported transactions?
Was cash used to settle the stock option exercise?
AI-generated analysis. How Rhea-AI works. Not financial advice.